Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis
Author:
Affiliation:
1. Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan
2. Department of Dermatology, Nippon Medical School, Tokyo, Japan
3. Department of Dermatology, Fujimoto Dermatology Clinic, Funabashi, Japan
Funder
Initiative for Realizing Diversity
MEXT
Publisher
Informa UK Limited
Subject
Dermatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09546634.2023.2291317
Reference30 articles.
1. Extent and Impact of Inadequate Disease Control in US Adults with a History of Moderate to Severe Atopic Dermatitis Following Introduction of New Treatments
2. Patient burden and quality of life in atopic dermatitis in US adults
3. The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus
4. Reconciling innate and acquired immunity in atopic dermatitis
5. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study;Pharmaceuticals;2024-04-18
2. Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan;Clinical Drug Investigation;2024-03-06
3. Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis;Journal of Dermatological Treatment;2024-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3